193 related articles for article (PubMed ID: 2834250)
21. Effect of the aldose reductase inhibitor tolrestat on nerve conduction velocity, Na/K ATPase activity, and polyols in red blood cells, sciatic nerve, kidney cortex, and kidney medulla of diabetic rats.
Raccah D; Coste T; Cameron NE; Dufayet D; Vague P; Hohman TC
J Diabetes Complications; 1998; 12(3):154-62. PubMed ID: 9618071
[TBL] [Abstract][Full Text] [Related]
22. Galactose feeding causes glomerular hyperperfusion: prevention by aldose reductase inhibition.
Bank N; Coco M; Aynedjian HS
Am J Physiol; 1989 Jun; 256(6 Pt 2):F994-9. PubMed ID: 2500030
[TBL] [Abstract][Full Text] [Related]
23. Binding of an aldose reductase inhibitor to renal glomeruli.
Cohen MP; Klepser H
Biochem Biophys Res Commun; 1985 Jun; 129(2):530-5. PubMed ID: 3925947
[TBL] [Abstract][Full Text] [Related]
24. Action of sorbinil in diabetic peripheral nerve. Relationship of polyol (sorbitol) pathway inhibition to a myo-inositol-mediated defect in sodium-potassium ATPase activity.
Greene DA; Lattimer SA
Diabetes; 1984 Aug; 33(8):712-6. PubMed ID: 6086432
[TBL] [Abstract][Full Text] [Related]
25. Recent advances in the therapy of diabetic peripheral neuropathy by means of an aldose reductase inhibitor.
Greene DA; Lattimer SA
Am J Med; 1985 Nov; 79(5A):13-7. PubMed ID: 3000175
[TBL] [Abstract][Full Text] [Related]
26. A sodium-pump defect in diabetic peripheral nerve corrected by sorbinil administration: relationship to myo-inositol metabolism and nerve conduction slowing.
Greene DA
Metabolism; 1986 Apr; 35(4 Suppl 1):60-5. PubMed ID: 2421135
[TBL] [Abstract][Full Text] [Related]
27. The effect of aldose reductase inhibitors on glomerular prostaglandin production and urinary albumin excretion in experimental diabetes mellitus.
Chang WP; Dimitriadis E; Allen T; Dunlop ME; Cooper M; Larkins RG
Diabetologia; 1991 Apr; 34(4):225-31. PubMed ID: 1906023
[TBL] [Abstract][Full Text] [Related]
28. Role of sorbitol accumulation and myo-inositol depletion in paranodal swelling of large myelinated nerve fibers in the insulin-deficient spontaneously diabetic bio-breeding rat. Reversal by insulin replacement, an aldose reductase inhibitor, and myo-inositol.
Greene DA; Chakrabarti S; Lattimer SA; Sima AA
J Clin Invest; 1987 May; 79(5):1479-85. PubMed ID: 3033025
[TBL] [Abstract][Full Text] [Related]
29. Effect of a new aldose reductase inhibitor, 8'-chloro-2',3'-dihydrospiro [pyrrolidine-3,6'(5'H)-pyrrolo[1,2,3-de] [1,4]benzoxazine]-2,5,5'- trione (ADN-138), on delayed motor nerve conduction velocity in streptozotocin-diabetic rats.
Hirata Y; Fujimori S; Okada K
Metabolism; 1988 Feb; 37(2):159-63. PubMed ID: 2828821
[TBL] [Abstract][Full Text] [Related]
30. The effects of aldose reductase inhibition on nerve sorbitol and myoinositol concentrations in diabetic and galactosemic rats.
Yue DK; Hanwell MA; Satchell PM; Handelsman DJ; Turtle JR
Metabolism; 1984 Dec; 33(12):1119-22. PubMed ID: 6438438
[TBL] [Abstract][Full Text] [Related]
31. [Role of aldose reductase inhibitors in the development of peripheral neuropathy in experimental diabetes].
Kuchmerovskaia TM; Donchenko GV; Klimenko AP; Chichkovskaia GV; Pakirbaeva LV; Kozitskiĭ ZIa; Efimov AS
Ukr Biokhim Zh (1978); 1997; 69(3):77-82. PubMed ID: 9505366
[TBL] [Abstract][Full Text] [Related]
32. Aldose reductase inhibitors and prevention of galactose cataracts in rats.
Unakar N; Tsui J; Johnson M
Invest Ophthalmol Vis Sci; 1989 Jul; 30(7):1623-32. PubMed ID: 2545646
[TBL] [Abstract][Full Text] [Related]
33. Effect of aldose reductase inhibitor (sorbinil) on integration of polyol pathway, pentose phosphate pathway, and glycolytic route in diabetic rat lens.
Gonzalez AM; Sochor M; Hothersall JS; McLean P
Diabetes; 1986 Nov; 35(11):1200-5. PubMed ID: 3093302
[TBL] [Abstract][Full Text] [Related]
34. Effects of sorbinil on glomerular structure and function in long-term-diabetic rats.
Mauer SM; Steffes MW; Azar S; Brown DM
Diabetes; 1989 Jul; 38(7):839-46. PubMed ID: 2525493
[TBL] [Abstract][Full Text] [Related]
35. Substance P levels in peripheral nerve, skin, atrial myocardium and gastrointestinal tract of rats with long-term diabetes mellitus. Effects of aldose reductase inhibition.
Willars GB; Calcutt NA; Compton AM; Tomlinson DR; Keen P
J Neurol Sci; 1989 Jun; 91(1-2):153-64. PubMed ID: 2473171
[TBL] [Abstract][Full Text] [Related]
36. An aldose reductase inhibitor but not myo-inositol blocks enhanced polyphosphoinositide turnover in peripheral nerve from diabetic rats.
Berti-Mattera L; Day N; Peterson RG; Eichberg J
Metabolism; 1996 Mar; 45(3):320-7. PubMed ID: 8606638
[TBL] [Abstract][Full Text] [Related]
37. Aldose reductase inhibitors and late complications of diabetes.
Benfield P
Drugs; 1986; 32 Suppl 2():43-55. PubMed ID: 3098544
[TBL] [Abstract][Full Text] [Related]
38. Uncoupling of attenuated myo-[3H]inositol uptake and dysfunction in Na(+)-K(+)-ATPase pumping activity in hypergalactosemic cultured bovine lens epithelial cells.
Cammarata PR; Tse D; Yorio T
Diabetes; 1991 Jun; 40(6):731-7. PubMed ID: 1645682
[TBL] [Abstract][Full Text] [Related]
39. Effect of galactose and glucose levels and sorbinil treatment on myo-inositol metabolism and Na+-K+ pump activity in cultured neuroblastoma cells.
Yorek MA; Dunlap JA; Leeney EM
Diabetes; 1989 Aug; 38(8):996-1004. PubMed ID: 2546844
[TBL] [Abstract][Full Text] [Related]
40. Effects of polyol-pathway inhibition and dietary myo-inositol on glomerular hemodynamic function in experimental diabetes mellitus in rats.
Goldfarb S; Ziyadeh FN; Kern EF; Simmons DA
Diabetes; 1991 Apr; 40(4):465-71. PubMed ID: 2010046
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
